Our approach started by asking a relatively naïve question: should tumor cells have the possibility to express in a “physiological way” MHC-II molecules, would they be capable to process and present putative tumor antigens, and would they even have the capacity to trigger naïve CD4+ TH cells specific for tumor? Here, CD4 is linked to neoplasm.